Hudson Bay Capital Management
SRNE

Hudson Bay Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Hudson Bay Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-87,759
Closed -$408K – 1399
2021
Q4 		$408K Buy
+87,759
New +$545K ﹤0.01% 868
2020
Q3 		– Sell
-180,000
Closed -$1.13M – 664
2020
Q2 		$1.13M Buy
+180,000
New +$689K 0.02% 374
2019
Q3 		– Sell
-662,059
Closed -$1.77M – 498
2019
Q2 		$1.77M Buy
+662,059
New +$2.38M 0.04% 288

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Hudson Bay Capital Management's SRNE Position: Q1 2022 in Review

Hudson Bay Capital Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2022, closing a stake of 87,759 shares — an estimated $408K sold.

Hudson Bay Capital Management first reported a position in SRNE in Q2 2019 and held it in 3 quarters. The position peaked at $1.77M in Q2 2019. 235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

  • Hudson Bay Capital Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 87,759 Sorrento Therapeutics, Inc. shares in Q1 2022, an estimated $408K.
  • Hudson Bay Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2019 and held it in 3 quarters.
  • Hudson Bay Capital Management's Sorrento Therapeutics, Inc. position peaked at $1.77M in Q2 2019.
  • 235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on Hudson Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.